MediciNova, Inc.
Market Cap
$72.36M
P/E Ratio
-6.12
EPS
$-0.24
Dividend Yield
0.00%
52-Week Range
$1.13 — $1.96
Volume
88.76K
Avg Volume
77.93K
Beta
0.60
P/E (TTM)
-6.12
Forward P/E
—
PEG Ratio
-0.06
P/S (TTM)
162.21
P/B (TTM)
1.59
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-0.26%
ROA (TTM)
-0.26%
ROIC
—
Gross Margin
0.08%
Operating Margin
-32.42%
Net Margin
—
Debt/Equity
0.00
Current Ratio
8.16
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-0.11%
EPS Growth (5Y)
-0.01%
Sales Growth (3Y)
-0.67%
Sales Growth (5Y)
-0.40%
EPS Est (This Year)
$-0.32
EPS Est (Next Year)
$-0.40
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.63
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
49.15M
Float
42.09M
Free Float %
85.65%
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
NASDAQ
IPO Date
2006-12-08
Employees
13
CEO
Yuichi Iwaki
Index Membership
—
Website
https://www.medicinova.com
MediciNova, Inc. (MNOV) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $72.36M, a P/E ratio of -6.12, MNOV is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare MNOV against other stocks using dozens of fundamental and technical filters.
MediciNova, Inc. (MNOV) has a trailing twelve-month (TTM) P/E ratio of -6.12. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, MediciNova, Inc. (MNOV) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
MediciNova, Inc. (MNOV) has a market capitalization of $72.36 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.